Methods and Means for Obtaining Modified Phenotypes

US2016355833A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016355833-A1
Application numberUS-201615212142-A
CountryUS
Kind codeA1
Filing dateJul 15, 2016
Priority dateAug 13, 1999
Publication dateDec 8, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated, target-specific RNA is provided by transcription of a chimeric gene comprising a promoter and a DNA region encoding the target-specific RNA.

First claim

Opening claim text (preview).

1 . (canceled) 2 . A chimeric DNA comprising a promoter operably linked to a target specific DNA region which encodes an unpolyadenylated hairpin RNA, wherein the target specific DNA region comprises a target specific sense nucleotide sequence and a target specific antisense nucleotide sequence, wherein the target specific antisense nucleotide sequence comprises 20 consecutive nucleotides in a sequence identical to the sequence of a complement of a part of an RNA molecule transcribed or produced from a nucleic acid of interest in an animal cell, wherein the target specific sense nucleotide sequence comprises 20 consecutive nucleotides in a sequence identical to the sequence of the part of the RNA molecule transcribed or produced from the nucleic acid of interest, wherein the target specific sense nucleotide sequence and the target specific antisense nucleotide sequence are separated and linked by a spacer sequence, such that the unpolyadenylated hairpin RNA resulting from transcription of the target specific DNA region comprises the spacer sequence located between sense and antisense nucleotide sequences in the unpolyadenylated hairpin RNA, and the sense and antisense nucleotide sequences are complementary to each other so as to form the unpolyadenylated hairpin RNA. 3 . The chimeric DNA of claim 2 , wherein said target specific sense nucleotide sequence corresponds to a translated region of the nucleic acid of interest. 4 . The chimeric DNA of claim 2 , wherein the target specific sense nucleotide sequence corresponds to an untranslated region of the RNA molecule produced from the nucleic acid of interest. 5 . The chimeric DNA of claim 2 , wherein the promoter is recognized by a eukaryotic RNA polymerase I or III and the DNA further comprises a terminator for the polymerase I or III. 6 . The chimeric DNA of claim 2 , wherein the nucleic acid of interest is a gene incorporated in the genome of the animal cell. 7 . The chimeric DNA of claim 2 , wherein the nucleic acid of interest is an endogenous gene of the animal cell. 8 . The chimeric DNA of claim 2 , wherein the nucleic acid of interest is a viral nucleic acid. 9 . The chimeric DNA of claim 2 , wherein the unpolyadenylated hairpin RNA lacks a 5′ cap structure. 10 . The chimeric DNA of claim 2 , wherein the spacer sequence has a length of from 4 to 200 basepairs. 11 . The chimeric DNA of claim 2 , wherein the promoter is a constitutive promoter. 12 . The chimeric DNA of claim 2 , wherein the promoter is an inducible promoter. 13 . The chimeric DNA of claim 2 , wherein the promoter is recognized by a single subunit RNA polymerase from a bacteriophage. 14 . The chimeric DNA of claim 2 , wherein the promoter is recognized by a eukaryotic RNA polymerase III and the DNA further comprises a terminator for the polymerase III. 15 . The chimeric DNA of claim 2 , wherein the target specific DNA region which is transcribed to form the unpolyadenylated hairpin RNA lacks a DNA region involved in 3′ end formation and polyadenylation. 16 . The chimeric DNA of claim 15 , wherein the target specific DNA region comprises a 3′ end formation signal and lacks a polyadenylation signal. 17 . An animal cell in culture comprising a chimeric DNA which comprises a promoter operably linked to a target specific DNA region which encodes an unpolyadenylated hairpin RNA, wherein the target specific DNA region comprises a target specific sense nucleotide sequence and a target specific antisense nucleotide sequence, wherein the target specific antisense nucleotide sequence comprises 20 consecutive nucleotides in a sequence identical to the sequence of a complement of a part of an RNA molecule transcribed or produced from a nucleic acid of interest in the animal cell, wherein the target specific sense nucleotide sequence comprises 20 consecutive nucleotides in a sequence identical to the sequence of the part of the RNA molecule transcribed or produced from the nucleic acid of interest, wherein the target specific sense nucleotide sequence and the target specific antisense nucleotide sequence are separated and linked by a spacer sequence, such that the unpolyadenylated hairpin RNA resulting from transcription of the target specific DNA region comprises the spacer sequence located between sense and antisense nucleotide sequences in the unpolyadenylated hairpin RNA, and wherein the sense and antisense nucleotide sequences are complementary to each other so as to form the unpolyadenylated hairpin RNA. 18 . The animal cell in culture of claim 17 , wherein the unpolyadenylated RNA is expressed in the cell.

Assignees

Inventors

Classifications

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Glucanases · CPC title

  • Beta-glucuronidase (3.2.1.31) · CPC title

  • involving modified lipid metabolism, e.g. seed oil composition · CPC title

  • for virus resistance · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016355833A1 cover?
Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated, target-specific RNA is provided by transcription of a chimeric gene comprising a promoter and a DNA region encoding the target-specific RNA.
Who is the assignee on this patent?
Commw Scient Ind Res Org
What technology area does this patent fall under?
Primary CPC classification C12N15/8218. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).